Eastgate Biotech Corp.
ETBI
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -18.08% | 24.66% | 37.60% | 30.46% | 28.35% |
| Total Depreciation and Amortization | 441.91% | -- | -- | -- | -65.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 80.54% | 2.48% | -11.61% | -2.42% | -85.40% |
| Change in Net Operating Assets | -45.05% | -10.02% | -50.46% | -40.01% | 40.08% |
| Cash from Operations | -649.00% | 91.31% | 0.89% | 32.38% | 62.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 699.28% | 72.93% | 0.67% | 5.05% | -36.95% |
| Total Debt Repaid | -1,636.90% | -1,129.09% | -47.27% | -12.22% | 82.86% |
| Issuance of Common Stock | 859.50% | 667.60% | -- | -- | -94.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 648.82% | 108.10% | -6.39% | -3.15% | -63.97% |
| Foreign Exchange rate Adjustments | 14,950.00% | 1,315.09% | 1,088.57% | 290.98% | 101.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 217.04% | 91.71% | 92.82% | 100.00% |